tiprankstipranks
KalVista Pharmaceuticals (DE:4XC1)
FRANKFURT:4XC1
Germany Market

KalVista Pharmaceuticals (4XC1) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
2Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
KalVista Pharmaceuticals’s (4XC1) Moving Averages Convergence Divergence (MACD) indicator is 0.73, suggesting KalVista Pharmaceuticals is a Sell.
KalVista Pharmaceuticals’s (4XC1) 20-Day exponential moving average is 14.88, while KalVista Pharmaceuticals’s (4XC1) share price is €17.1, making it a Buy.
KalVista Pharmaceuticals’s (4XC1) 50-Day exponential moving average is 13.96, while KalVista Pharmaceuticals’s (4XC1) share price is €17.1, making it a Buy.

KalVista Pharmaceuticals (4XC1) Pivot Points

Apr 03, 2026, 05:50 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.50
15.50
15.50
15.50
15.50
15.50
15.50
Fibonacci
15.50
15.50
15.50
15.50
15.50
15.50
15.50
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

KalVista Pharmaceuticals (4XC1) Moving Averages

Apr 03, 2026, 05:50 PM
Period
Simple
Exponential
MA5
16.02Buy
16.09Buy
MA10
15.12Buy
15.51Buy
MA20
14.80Buy
14.88Buy
MA50
13.62Buy
13.96Buy
MA100
13.08Buy
13.17Buy
MA200
12.00Buy
12.25Buy
KalVista Pharmaceuticals’s (4XC1) 10-Day exponential moving average is 15.51, while KalVista Pharmaceuticals’s (4XC1) share price is €17.1, making it a Buy.
KalVista Pharmaceuticals’s (4XC1) 100-Day exponential moving average is 13.17, while KalVista Pharmaceuticals’s (4XC1) share price is €17.1, making it a Buy.
KalVista Pharmaceuticals’s (4XC1) stock price is €17.1 and KalVista Pharmaceuticals’s (4XC1) 50-day simple moving average is 13.62, creating a Buy signal.
KalVista Pharmaceuticals’s (4XC1) stock price is €17.1 and KalVista Pharmaceuticals’s (4XC1) 100-day simple moving average is 13.08, creating a Buy signal.
KalVista Pharmaceuticals’s (4XC1) stock price is €17.1 and KalVista Pharmaceuticals’s (4XC1) 200-day simple moving average is 12.00, creating a Buy signal.

KalVista Pharmaceuticals (4XC1) Technical Indicators

Apr 03, 2026, 05:50 PM
Name
Value
Implied Action
RSI (14)
65.58
Neutral
STOCH (9,6)
88.24
Sell
STOCHRSI (14)
88.24
Sell
MACD (12,26)
0.73
Sell
ADX (14)
20.13
Neutral
Williams %R
0.00
Buy
CCI (14)
194.97
Sell
ATR (14)
0.68
-
Ultimate Oscillator
70.61
Buy
ROC
13.25
Buy
KalVista Pharmaceuticals’s (4XC1) Relative Strength Index (RSI) is 65.58, creating a Neutral signal.
KalVista Pharmaceuticals’s (4XC1) Trend Strength Indicator (ADX) is 20.13, creating a Neutral signal.
KalVista Pharmaceuticals’s (4XC1) Commodity Channel Index (CCI) is 194.97, creating a Sell signal.
KalVista Pharmaceuticals’s (4XC1) Price Rate of Change (ROC) is 13.25, creating a Buy signal.

FAQ

Is 4XC1 a Buy, Hold, or Sell?
Based on 4XC1’s technical indicators, 4XC1 is a Strong Buy.
    What is 4XC1’s RSI (14)?
    4XC1’s RSI (14) is 65.58, which suggests 4XC1 is a Neutral.
      What is 4XC1’s MACD?
      4XC1’s MACD is 0.73, which suggests 4XC1 is a Sell.
        What is 4XC1’s 5-day moving average?
        4XC1’s 5-day moving average is 16.02, which suggests 4XC1 is a Buy.
          What is 4XC1’s 20-day moving average?
          4XC1 20-day moving average is 14.80, which suggests 4XC1 is a Buy.
            What is 4XC1’s 50-day moving average?
            4XC1’s 50-day moving average is 13.62, which suggests 4XC1 is a Buy.
              What is 4XC1’s 200-day moving average?
              4XC1’s 200-day moving average is 12.00, which suggests 4XC1 is a Buy.
                What is 4XC1’s Williams % R (14)?
                4XC1’s Williams % R (14) is 0.00, which suggests 4XC1 is a Buy.
                  What is 4XC1’s CCI (14)?
                  4XC1’s CCI (14) is 194.97, which suggests 4XC1 is a Sell.
                    What is the share price of KalVista Pharmaceuticals?